Nov 2019

ANTG MEETS IMPORTANT MILESTONE WITH MEDICINAL CANNABIS LISTING ON THE AUSTRALIAN REGISTER OF THERAPEUTICS GOODS

We’re thrilled to announce one of our proprietary medicinal cannabis strains, EVE Cannabis Indica, has been listed on the Australian Register of Therapeutic Goods (ARTG). The ARTG is a reference of therapeutic goods that can lawfully be supplied in or exported from Australia. According to the TGA, in order to be entered onto the ARTG, therapeutic goods need to be “assessed as meeting the requirements for quality, safety and where appropriate efficacy and/or performance”.  The same conditions need to be met for export. Our team is pleased to be able to continue to pursue their goal of improving lives through high-quality, pure, effective medicinal cannabis. Read more here.

We’re thrilled to announce we have received our export licence from the Drug Control Section of the ODC (Office of Drug Control). We’re firmly on course to continue to lead the way and be the first medicinal cannabis company in Australia to export cannabis flower to the EU since export was legalised in 2018.

READ MORE >

We have successfully passed three consecutive TGO93 and TGO100 tests on our medicinal cannabis products since our first commercial harvest at the end of 2019.

READ MORE >

In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >